SPY312.18+4.10 1.33%
DIA263.17+5.32 2.06%
IXIC9,682.91+74.54 0.78%

B. Riley FBR Maintains Buy on Madrigal Pharmaceuticals, Raises Price Target to $174

B. Riley FBR maintains Madrigal Pharmaceuticals (NASDAQ:MDGL) with a Buy and raises the price target from $134 to $174.

Benzinga · 05/22/2020 10:46

B. Riley FBR maintains Madrigal Pharmaceuticals (NASDAQ:MDGL) with a Buy and raises the price target from $134 to $174.